Clinical trials
Active, not recruiting Phase 4 trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 3 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 4 |
| Novartis Pharmaceuticals | 3 |
| GlaxoSmithKline | 2 |
| Seoul National University Hospital | 2 |
| Amgen | 1 |
| Asan Medical Center | 1 |
| Bayer | 1 |
| Chong Kun Dang Pharmaceutical | 1 |
| Eisai Korea Inc. | 1 |
| Exelixis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 6 |
| Asthma | 2 |
| Cardiovascular Diseases | 2 |
| Graft vs Host Disease | 2 |
| Hepatitis B, Chronic | 2 |
| Plaque, Atherosclerotic | 2 |
| Renal Insufficiency, Chronic | 2 |
| Angina, Stable | 1 |
| Antiphospholipid Syndrome | 1 |
| Atrial Fibrillation | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.